Activist 13D/13G Filings - Sofinnova Venture Partners IX L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-02-03
7:04 pm
Sale
13DGalera Therapeutics, Inc.
GRTX
Sofinnova Venture Partners IX L.P.3,083,712
10.8%
-1,098decrease
(-0.04%)
View
2021-03-04
06:17 am
Sale
13DEntasis Therapeutics Holdings Inc.
ETTX
Sofinnova Venture Partners IX L.P.0
0%
-1,180,178decrease
(Position Closed)
View
2020-08-19
11:58 am
Purchase
13DCheckmate Pharmaceuticals, Inc.
CMPI
Sofinnova Venture Partners IX L.P.3,606,707
16.8%
3,606,707increase
(New Position)
View
2020-06-05
4:48 pm
Sale
13DIterum Therapeutics plc
ITRM
Sofinnova Venture Partners IX L.P.6,154
0%
-1,726,514decrease
(-99.64%)
View
2020-04-27
1:04 pm
Sale
13DMerus N.V.
MRUS
Sofinnova Venture Partners IX L.P.1,311,039
4.5%
-439,060decrease
(-25.09%)
View
2020-02-13
1:26 pm
Unchanged
13GChiasma, Inc.
CHMA
Sofinnova Venture Partners IX L.P.1,767,102
4.2%
0
(Unchanged)
View
2020-01-24
9:51 pm
Purchase
13DIterum Therapeutics plc
ITRM
Sofinnova Venture Partners IX L.P.1,732,668
11.6%
6,154increase
(+0.36%)
View
2019-11-21
8:05 pm
Purchase
13DNextCure, Inc.
NXTC
Sofinnova Venture Partners IX L.P.2,671,856
10%
150,000increase
(+5.95%)
View
2019-11-19
8:48 pm
Purchase
13DGalera Therapeutics, Inc.
GRTX
Sofinnova Venture Partners IX L.P.3,084,810
12.7%
3,084,810increase
(New Position)
View
2019-05-16
8:46 pm
Purchase
13DNextCure, Inc.
NXTC
Sofinnova Venture Partners IX L.P.2,521,856
11.1%
2,521,856increase
(New Position)
View
2019-03-27
6:03 pm
Sale
13DPDS Biotechnology Corp
EDGE
Sofinnova Venture Partners IX L.P.142,635
2.7%
-2,710,076decrease
(-95.00%)
View
2019-02-11
8:02 pm
Sale
13DAscendis Pharma A/S
ASND
Sofinnova Venture Partners IX L.P.2,044,001
4.9%
-488,054decrease
(-19.28%)
View
2019-02-11
7:43 pm
Sale
13DaTyr Pharma, Inc.
LIFE
Sofinnova Venture Partners IX L.P.0
0%
-1,694,528decrease
(Position Closed)
View
2019-01-11
3:54 pm
Purchase
13DAscendis Pharma A/S
ASND
Sofinnova Venture Partners IX L.P.2,532,055
6%
293,791increase
(+13.13%)
View